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To evaluate cardiac iovolvrment in primary antiphospholipid 
syndrome, two-dimensional and Doppler echwardiographic rtud- 
ies were performed in 34 coosecutive patierrts with th6 syndrome. 
All patients had an inrreawd level of serum snlicardiolip$n 
ahtibadiff with no evidence of malignancy or systemic lupus 
erythenatosus. The clinical manifestations of primary antiphas- 
pholipitl syndrwnc were aferlnl thrombosis in 14 patients. renous 
thrambmis in 6 and recurrent Fetal toss in 14. Valvular lesions 
were observed on two-dbnmsionrd echorardiagraph~ in 11 pa. 
tienis (32%) (9 wome” and 2 me”), aged 24 to 57 years (mean f 
1 SD 36 * IO). 
Abnormal echornrdiographlc findings were observed in 9 
W%) “f I4 patients with arterial thrombosis YWWS 1 ll7R, al 6 
patii”ts with YLIIOUS thrombc& and 1 (7%) of 14 patients with 
recurrent fetal loss. The most mnmcm echacnrdiographic abnor- 
lnality was mitral leaflet thickening, Lund in five palients: this 
An elevated serum level of antiphosphohpid anlihodies has 
been associated with thmmboembolic phenomcnd w c A 
tients with an autoimmune disease such as systemic lupus 
erythematosus or in those with a malignant tumor (I). Other 
patients with an autoimmune disease and increased scrurn 
anriphGspholipid antibodies have no diagnostic criteria fur 
systemic lupus erythcmatosus 12) and no evidence for ma- 
lignancy and therefore this group has been classified a% 
having primary antiphospholipid syndrome (3). Clinical man- 
ifestations of this syndrome are recurrenl feLal loss or 
arterial and venous thrombosis 13,41. However. the reason 
for the appearance of a vascular comphcation tn a Elven 
padem with primary antiphospholipid syndrome is unclear. 
Cardiac valvular lesions have been reported (5-l II in 
nonhomogeneous groups of pattents \cith systemic lupus 
erythematosus and lupus-like syndromes. The present study 
was undertaken to evaluale the rrequency and characrens- 
rics of valvular lesions in patie”& with primary anriphobpho- 
ws awxiated uith mitral regurgitation in three snd with cam- 
bined mild milral stenos!s and reeureitation in one patient. 
Localized ~uubral~ular mitral thickening was obsprred’in one 
patient and calcification of the anulus in analher. Aortic valve 
thickening uas ohser~ed in Lwo patieni% one orvhom also had a 
moderate dgreeolaortic regurgitation. Vegetalion.likc l&as on 
the milral or aortic valve were found in iwo patients. 
It is concluded that vahular tesions are cammanly found in 
primav antiphosphalipid syndrome, particularly when the sy.7. 
dromo is manifested by peripheral arterial ~hramhosb. The 
location and appearance of valvular lesions in this syndrome are 
hetemgeneaur. Ilmt patientz hare no clinically significant ~al\u- 
lar disease. Two-dimensional and Doppler echacardiyrapbic 
studies are often informathe in lhese patients. 
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lipid syndrome and to determine whether such lesions are 
r.rre!nte aith thmmboembolic phenomena. 
Methods 
Study patients. The swdy group included 34 consecutive 
patients with the primary antiphospholipid syndrome diag- 
nosed and followed up in the hematology and obstetrics 
clinic\ at the Rambam Medical Center. There were 29 
women aind 5 men. whose mean age (rl SD) was 3’ 5 I3 
years. 
Twenty patients were referred because of vascular man- 
ifcstalions. Ai;erial thrombosis was found in 14 parientr 
(cerebmvascular accident or transient irchemic attack in 9 
patients and femorapoplitesl obstruction in 5). Venous 
thrombotic manifestations were deep wn thrombosis in six 
p&w?. including two wth pulmonary embolism. In I4 
young women. Ihe reason for serum anticardiolipin antibod- 
ies exammntion was three or more early or lalr abortions. 
intrwwinc fetal deaath or premaure delivery. The patients‘ 
hIglory war carefully examined to encludc rheumatic heart 
disease and haclerial endocardids. 
A.\ II ~on~ml~ronp, 22 consecutive patiems with clinically 
suspected emholic arterial ucclusion (cerehrovascular acci- 
dent in Xl and fcmoropopliteal obstruclion in 21 WhoUr 
overt hear1 disease were studied. These patients were re- 
[erred for cchoaardiography for the dctcction of nccull 
emhoti, sources during the corresponding 6.month period of 
the study. They included 17 men and 5 women whose auc 
tanged from 30 to 81 years (mean + I SD 57 t Id). 
Laboratory criferia for evidence of antipbospbolipid nnti- 
bodies. Thcsr included incrcascd (>?O U) serum levels of 
lmmunoglobulin G 11gGl anticardiolipin antibodies ab as- 
sea\ed by cnzymc-linked immunoswbent assay (according 
to Harris et al. [ 1211 and pre~enee of lupus anricnaguhml as 
defined by a positive diluted thromboplastin litration index 
> I.3 at 11200 final dilution (13). 
Two-dimensional and Doppler echocardiography. All 
cchucardiofraphic atudles were performed by one enperi- 
cnccd operator 1S.A.R.) who was unaware of the patients’ 
dinical information. Two-dimensional and pulsed Doppler 
echocardiopraphic images were acquired with a Hewlett- 
Packard 77020A ultrasound imagerequipped with a 2.5-MHz 
phased array transducer. Continuous wave Doppler record- 
ings were obtained with a I .9-MHz nonimaging transducer 
conncctcd to the Hewlett-Packard imagcr. Standard two- 
dimensional and M-mode echocardiopraphic images were 
obtained m the parastemal. apical and subcortal views and 
recorded on aO.S-in. (I.27 cm) videotape with VHS format. 
TIIP prcseut~c 0s rnitrrrl or iriw.~pid re,arrrairnrion rt’o> 
Jc$ar~r ac a systolic high velocity jet that extended from the 
valve into the corresponding atrium. The left and right atria 
were carefully scanned to identify ihe maximal extenl of the 
rcpurgit:mt jet. Aortic regurgitation was defined as a diastolic 
high velocityjet that extended from the m-tic valve into the 
left vcnlricular outpow tract. The left ventricle was scanned 
by using apical views IO identify the maximal extent of the 
regurgitant jet. 
The continuous wave Doppler transducer was placed at 
the apical position and optimally angulatcd according to the 
sound beam to record the mitral. aortic and tricuspid valve 
Row velocities. 
Ecbocardiographic evaluation of valve morphology. The 
morphologic features of the mitral valve were characterized 
according to leaflet thickening and motion and the structure 
of the subvalvular apparatus. Thickening of mitral leaflets 
>5 mm noted on multiple echocordiogwphic views was 
defined as abnormal (14). A localized and mobile echogenic 
rrmss on an otherwise normal-appearing valve was defined as 
a vegetation-like lesion. 
Grading of valvular reRurgilation by Doppler ultrasound. 
To assess the severity of mitral and iricuspid regurgitation. 
tbc cxtcnt of the systolic jet into the left and the right atrium. 
respectively. wab evaluated. Mild regurgitation was defined 
when thr regurgitant jet extended into less lhan half of the 
atrium. Fvloderate regurgitation was defined when the jet 
extended into >50% of the atrium and severe regurgitation 
when filling of the entire atrium was observed (IS). 
Aortic valve regurgitation was graded according to the 
extension of the regurgitant jet into the left ventricular 
outflow tram. Mild aortic regurgitation was defined as a 
diastolic jet detected below the tip of the anterior mitral 
leaflet. In moderate aortic regurgitation. the jet extended 
below the tip ofthe anterior mitral leaflet. whereas in severe 
aontc regurgitation, it extended beyond the papillary mus- 
cles tlht. 
Doppler calculations. Mitral valve area was calculated as 
?ZO/(pressure half-time) (17). Peak pressure gradients were 
calculated from peak velocities with use of the modified 
Bernoulli equation OP = 4V’). where P = pressure and V = 
volume (18). Mean pressure gradients were obtained by 
planimetry with use of ihe software package of the Hc~~lelt- 
Packard 77020A ultrasound imager. 
Results 
Patient characteristics. Valvulat lesions were observed 
on two-dimensional echocardiography in I I (12%) of the 34 
patients (9 women and 2 men) whose age ranged from 24 lo 
57 years tmean t I SD 36 2 101. 
Demographic, clinical and echocatdiogrdphic character- 
istics of the parienls with primary antiphospholipid syn- 
dmme and valvular lesions are summarized in Table I. The 
age of patients with a valvular lesion was not significantly 
different from that of patients without a valvular lesion (36 2 
IO vs. 34 5 IO years. respectively: p = NS by unpaired 
Student’s I test). 
Correlation of valvular lesions wilb Use clinical manifesta- 
tions of primary antiphosphdipid sysnfmme. An abnormal 
echocardiographic study was found in 9 (64%) of the I4 
patients witharterial thrombosiscompared withonly I (17%) 
of 6 patients with venous thrombosis and I (7%) of I4 
patients with recurrent fetal loss (p c 0.01 arterial thrombo- 
sis vs. venous thrombosis: p < 0.001 arterial thrombosis vs. 
fetal loss by difference of two proportions). In the control 
group, only I (4.5%) of 22 patients had a vegetation on the 
mitral valve. 
Echecardiographic appearance of valvular lesions. The 
mitral valve was most commonly involved, with echocardio- 
graphic abnormalities found in eight patients. Several pat- 
terns of mitral valve involvement were observed. The most 
common pattern found in five patients was leaflet thickening. 
In one patient (Patient I). a 24-year old woman, leaflet 
motion was resrricted. resulting in mild mitral slenosir and 
reeureitation (mitral valve area I.9 ems calculaied bv the 
owpcnicnr. Figure 2 is a&acing from a 39-year old man with 
localized thickening of lhe mitral apparatus at the chordal 
Icvel. Another 27.year old woman (Patient 8) had a bcavily 
calcified mitral anulus with severe mitral regurgitation and 
left ventricular and left atrial enlargement. A distinctive 
pattern ofmitrdl disease was a vegetation-like lesion. Figure 
3 presents a tracing from a B-year old woman (Patient 5) 
with a mobile echagenic mass attxhed to the posrer~x 
leaflet of the mitral valve. 
Mitral lesions were typically associated with !~mc dqrc~ 
of mitral regurgitation on Doppler cchocardiogqh~ in 
seven (88%) of eight patients. Regurgitation was mild in four 
patients. moderate in two and sewre in one. The patG~nt 
with sexre mitral regurgitation had <ongestive bear1 Glare 
treated with digoxin and diuretic drugs. 
Aorric valve kvolvenirnr w’u.! frxrnd bz ~irrw poriw! > 
Aorlic valve lhickcning ~h’as found in two patients (Patients 7 
and9). In both patients, the aorlic valve had ihrec cusps and 
the thickening was more prom&m al the base of the cusps 
(Fig. 4). In a 43.year old woman (Patient 10). a veE+zelation- 
like. echogenic and mobile lesion prolapsing into the lefi 
ventricular outflow tract duringdiastole was observed on the 
noncomnary cusp. Moderate aortic regurgiution was re- 
corded in one’ of the three pat~enr, Gth an aorlic valve 
t”cwn; illI three were NO years of q’-c. 
Discussion 
Peeralencc of valvular lesions in patients with primary 
antiphcspholipid syndrome. The presenl rlndy dcmonstratcs 
that cardiac valve abnorrmalitie~ arc common in patientr with 
primary anriphospholipid syndrome. WC observed an overall 
Figure 1. Yar~enl I. Echocardiograms in the paraaIemal long-axis 
view Wt pancll and short-axis vices I” dinstole (middle panell and 
r)htolc Iright pnrl) in d ?I-year old warnan. Marked lhlckening of 
the meral lraflcts i\ noted (white arwA aith reslricted m&n in 
diasule. reuhing in combined mild milml regurgiration and steno- 
sis. LA = left atrium: LV = lell vcnricle: mv : mitral valve. 
Figure 2. Patienr 2. Apical four-chamber view in a 39-year old man. 
Thickening of Ihe subvalvular mitral apparatus with fusion or 
chordac icndincm is noted (white arrow). RV = right venlric!e; 
other abbrewalicms as III Figure I. 
32% incidence of cardiac involvement. Similar rcsul~s have 
been observed by other investigators (Xl I). 
This incidence of valvular abnormalities in patients with 
primary antiphospholipid syndrome is significantly higher 
than the incidence noted in patients with idiopathic systemic 
thromboembolism. Although our control patients were sig- 
nificantl) older than the study patients, only one control 
patient had a lesion on the mitral valve. Similar data regard- 
ing !he yield of echocardiography in idiopathic sysiemic 
thromboembolism have been published by Loveit et al. (191 
from the Mayo Clinic. 
Echocardiographic appearance of valvular lesions in pri- 
mary antiphospholipid syndrome. In 1924, Libman and 
Sacks (201 described vegetations that were free of bacteria. 
They iniroduced the ~er:s “atypical verrucous endocardi- 
tis.” later related to systemic lupus erythematosus. Bacte- 
Flgare 4. Patient 9. Pamsternal lanp-axis view in a 4%year old 
woman. Thickening of the basal portion of the tight aortic cusp is 
noted (while armwl. This patient had a moderate degree of aortic 
lao) qurgjta~ion. Abbreviations as in Figure 3. 
ria-free verrocae have been recognized in other conditions, 
such as debilitating states and malignancies. frequently 
termed “nonbacterial thrombotir endocarditis.” These le- 
sions mostfrequemly appear on left-sided valves. but can be 
found on the valvular ring, chordae tendineae or any other 
location of ventricular or &al endocardium (20,21). 
Granulation tissue may thicken and deform the valve 
during the healing process. Although this deformation is 
rarely clinically significant, cases with severe valvular rc- 
gurgitation requiring valve replacement have been reported 
(22,231. There is a remarkable similarity in the location 
and echocardiographic appearance of valvular lesions in 
patients with rhe nonbacterial thrombotic endocarditis just 
described and those of the valvular lesiws found in our 
study patients. 
Figure 3. Patient 5. Paraslcrnal long-axis view 
OeN panel1 and apical four-chamber view (r&hi 
panel) in a B-year old woman. A vegelation. 
like mobile and rchogenic mass is attached to 
the poswior mitral leaflet tarrowsl. 80 = rona: 
la = left atrium: other abbreviations as in 
Figurer I and 2. 
Abhough no pawn, kad a h,s,ory of rheumatic fever. the 
poseibilily ofcoincidental rheumatic hear, disease m pawnr 
with primary antiphospholipid syndrome has been conw- 
med. The echocardiopraphic appearance of valrular lesions 
in primary anriphosphclip;d syndrome is remarkably d,f- 
Wren, from that m rheumatic ~alwdar di\easc. In our p3- 
tienls wilh primary anfipkospholipid syndrome and mitral 
valve disease. there was no commixwal fusion or valve 
doming and poslerior leafic! motion wa2 unrcstrwed. Suh- 
valv~lar mitral disease. commonly seen in rlleumat~c hcarr 
disease. was Fotrnd in only one patient IFig. 1) and had a very 
unusual morphology that was a,ypical for rheumaric mi,ral 
disease. 
Aortic valve thickening in patier& with primary sntiphos- 
pholipid syndrome was more prominent at the base of the 
cusp. No patient had combined aortic and mitral valve 
lesions commx,y :sen in rheumatic hear, diseil,e. 
Clinical manifestations of patients with primary antiphos- 
pholipid syndrome. Parienrs wi,h carduc valvular lenon% 
v&e typically young women. However, gender and age m 
this group did no, d&r from those in patients with primary 
antiphospholipid syndrome without cardiac involvement. 
Our fmdings d~monetrate a e!ear preponderance of valvular 
lesions whenever primary arrtiphospholipid syndrome ,9 
manifested by arterial thrombosis. An abnormal echocardio- 
graphic study was found in 9 (64%) of I4 patients with 
WI&I thrombosis compared with 17% of pawnts eirh 
venous thrombosis and 7% of patients wilh fetal loss only. 
7jte pofhogrnesis of fhronrbosis in patients with primary 
antiphospholipid syndrome has no, yet been elucidated. 
Suggested potenlial mechanisms for thrombosis include in, 
creased platelet aclivity, decreased aniitnrombin III plilsma 
levels. inhibition of prostacyclin relew from vascular en- 
dothelial cells and inhibition of the protein C-protein S 
thrombomodulin system 124.2.0. In addition, ,mpaired h- 
brinotysis manifested by decreased tissue plasminogen act,- 
vator release from endothelial cells and increaxd plasmiso- 
gen activator inhibitor have recently (26) been observed jo 
patients with primary antiphospholipid syndrome. However. 
these abnormalities have been reported in a minority of 
patients and cannot ycl predict whethc, a particular patient 
with primary antiphospholipid syndrome will develop rhrom- 
boembolism. 
Vdvdur enddwlid dmu~~ may rrsul~ from the turbu- 
lence and jet effc;~ ihal arc most prommcnt in the left side of 
the heart. In nurmal persons. antithrombonc mechanisms 
prevent the formation of tkromhus on the injured endotke- 
lium. Ac discussed. patients wi,h primary antiphospholipid 
syndrome may have impaired antithrombot,c mcchan,sm< 
leading to platelet and fibrin deposItion. 
The nowprcijic MIIWP of dw plnrdcr:fibr;/~ throsrhrr \ IS 
emphasized hy irr occ~~ence as a result of numcro,,~ types 
of s,ress or injury. This explains why valvular lesions in 
primary antiphospholipid syndrome have a location and 
appearance similar to those in other diseaea with associated 
hkhough endolhclial damage may explain both cndocar- 
dial and locab peripheral artenal thrombosis. it :s aI1 unclear 
whether cardiac valruiar lewn~ may be th? origin of pcriph- 
erai anerial embolism in primary arwphosphohpid syn- 
drome. 
Conclurions. Milrdl and noflic valve leston are com- 
monlr found in the primur~ antipho$pholipid syndrome. 
par~~cubrl~ rihen msnifesred by peripheral arrcrial throm- 
ho%. Uos, parients have no clinically rignificant valvular 
disca>e. The locatton and appearance of valrular ksiuns in 
pnmar~ antlphorpholipid syndrome art not specific. Similar 
lesions can be found in other dwaser with nonbacterial 
rhromhotlc endocarditis. Two-dimensional and Doppler 
rchocxdiograpkic wckniques are of!en informs&e jn dc- 
,rc,ing v;~lrutar involvement in pr,mar) anriphospholipid 
\yndrome. 
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